Lifevantage Corporation (NASDAQ:LFVN) Declares Quarterly Dividend of $0.05

Key Points

• LifeVantage declared a quarterly dividend of $0.05 per share, payable September 15 to shareholders of record on September 1. The dividend is annualized at $0.20 per share and yields approximately 3.0%.
• The dividend appears well covered, with an 18.5% current payout ratio; analysts expect next year’s earnings to support an estimated payout ratio of 30.8%.
• LFVN shares rose 0.6% to $6.69, while institutional ownership stands at 35.32% following increased positions from several investment firms, including JPMorgan Chase.

Lifevantage Corporation (NASDAQ:LFVN - Get Free Report) declared a quarterly dividend on Friday, August 21st. Shareholders of record on Tuesday, September 1st will be paid a dividend of 0.05 per share on Tuesday, September 15th. This represents a c) annualized dividend and a yield of 3.0%. The ex-dividend date of this dividend is Tuesday, September 1st.

Lifevantage has a dividend payout ratio of 18.5% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Lifevantage to earn $0.65 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 30.8%.

Lifevantage Stock Up 0.6%

Shares of NASDAQ:LFVN traded up $0.04 during trading on Friday, reaching $6.69. 40,323 shares of the company traded hands, compared to its average volume of 277,717. The firm has a market capitalization of $84.43 million, a PE ratio of 14.87 and a beta of 0.72. Lifevantage has a 52 week low of $3.90 and a 52 week high of $14.28. The company's 50 day moving average is $6.43 and its two-hundred day moving average is $5.78.

Institutional Investors Weigh In On Lifevantage

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Jane Street Group LLC increased its stake in shares of Lifevantage by 5.4% in the first quarter. Jane Street Group LLC now owns 36,567 shares of the company's stock valued at $533,000 after buying an additional 1,877 shares during the period. Cetera Investment Advisers boosted its position in Lifevantage by 10.8% during the 2nd quarter. Cetera Investment Advisers now owns 20,098 shares of the company's stock worth $263,000 after buying an additional 1,954 shares during the period. Bank of New York Mellon Corp grew its holdings in Lifevantage by 11.9% during the 1st quarter. Bank of New York Mellon Corp now owns 33,547 shares of the company's stock worth $145,000 after acquiring an additional 3,571 shares during the last quarter. Invesco Ltd. grew its holdings in Lifevantage by 13.6% during the 4th quarter. Invesco Ltd. now owns 30,085 shares of the company's stock worth $185,000 after acquiring an additional 3,603 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its position in Lifevantage by 870.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company's stock valued at $66,000 after acquiring an additional 4,499 shares during the period. 35.32% of the stock is owned by institutional investors.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company's flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source